121 related articles for article (PubMed ID: 12099513)
21. Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo.
Jones RG; Parsons M; Bonnard M; Chan VS; Yeh WC; Woodgett JR; Ohashi PS
J Exp Med; 2000 May; 191(10):1721-34. PubMed ID: 10811865
[TBL] [Abstract][Full Text] [Related]
22. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
Wells AD; Walsh MC; Bluestone JA; Turka LA
J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
[TBL] [Abstract][Full Text] [Related]
23. Induction of interleukin-2 unresponsiveness and down-regulation of the JAK-STAT system upon activation through the T cell receptor.
Miyatake S; Sakuma M; Saito T
Eur J Immunol; 1997 Jul; 27(7):1816-23. PubMed ID: 9247597
[TBL] [Abstract][Full Text] [Related]
24. CD28-induced cytokine production and proliferation by thymocytes are differentially regulated by the p59fyn tyrosine kinase.
Ong CJ; Lim AS; Teh HS
J Immunol; 1997 Sep; 159(5):2169-76. PubMed ID: 9278304
[TBL] [Abstract][Full Text] [Related]
25. Constitutive expression of Bcl-xL or Bcl-2 prevents peptide antigen-induced T cell deletion but does not influence T cell homeostasis after a viral infection.
Petschner F; Zimmerman C; Strasser A; Grillot D; Nunez G; Pircher H
Eur J Immunol; 1998 Feb; 28(2):560-9. PubMed ID: 9521066
[TBL] [Abstract][Full Text] [Related]
26. Stronger correlation of bcl-3 than bcl-2, bcl-xL, costimulation, or antioxidants with adjuvant-induced T cell survival.
Mitchell TC; Teague TK; Hildeman DA; Bender J; Rees WA; Kedl RM; Swanson B; Kappler JW; Marrack P
Ann N Y Acad Sci; 2002 Dec; 975():114-31. PubMed ID: 12538159
[TBL] [Abstract][Full Text] [Related]
27. A point mutation in CD28 distinguishes proliferative signals from survival signals.
Okkenhaug K; Wu L; Garza KM; La Rose J; Khoo W; Odermatt B; Mak TW; Ohashi PS; Rottapel R
Nat Immunol; 2001 Apr; 2(4):325-32. PubMed ID: 11276203
[TBL] [Abstract][Full Text] [Related]
28. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death.
Van Parijs L; Refaeli Y; Lord JD; Nelson BH; Abbas AK; Baltimore D
Immunity; 1999 Sep; 11(3):281-8. PubMed ID: 10514006
[TBL] [Abstract][Full Text] [Related]
29. Apoptosis and Bcl-2 expression in cultured murine splenic T cells.
Broome HE; Dargan CM; Bessent EF; Krajewski S; Reed JC
Immunology; 1995 Mar; 84(3):375-82. PubMed ID: 7751019
[TBL] [Abstract][Full Text] [Related]
30. Regulation of apoptosis in mature alphabeta+CD4-CD8- antigen-specific suppressor T cell clones.
Khan Q; Penninger JM; Yang L; Marra LE; Kozieradzki I; Zhang L
J Immunol; 1999 May; 162(10):5860-7. PubMed ID: 10229821
[TBL] [Abstract][Full Text] [Related]
31. Interleukin 2-mediated uncoupling of T cell receptor alpha/beta from CD3 signaling.
Haughn L; Leung B; Boise L; Veillette A; Thompson C; Julius M
J Exp Med; 1998 Nov; 188(9):1575-86. PubMed ID: 9802969
[TBL] [Abstract][Full Text] [Related]
32. IL-2 activation of a PI3K-dependent STAT3 serine phosphorylation pathway in primary human T cells.
Fung MM; Rohwer F; McGuire KL
Cell Signal; 2003 Jun; 15(6):625-36. PubMed ID: 12681450
[TBL] [Abstract][Full Text] [Related]
33. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.
Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D
Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506
[TBL] [Abstract][Full Text] [Related]
34. Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division.
Boise LH; Minn AJ; June CH; Lindsten T; Thompson CB
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5491-5. PubMed ID: 7777536
[TBL] [Abstract][Full Text] [Related]
35. Clonal anergy is maintained independently of T cell proliferation.
Colombetti S; Benigni F; Basso V; Mondino A
J Immunol; 2002 Dec; 169(11):6178-86. PubMed ID: 12444122
[TBL] [Abstract][Full Text] [Related]
36. Introduction of the cell survival gene bcl-xL improves the viability of CTLL-2 cells without affecting their IL-2 proliferative response. Implications for the development of bioassays.
Boise LH; McShan CL; Thompson CB
J Immunol Methods; 1996 May; 191(2):143-8. PubMed ID: 8666833
[TBL] [Abstract][Full Text] [Related]
37. T cell costimulation through CD28 depends on induction of the Bcl-xgamma isoform: analysis of Bcl-xgamma-deficient mice.
Ye Q; Press B; Kissler S; Yang XF; Lu L; Bassing CH; Sleckman BP; Jansson M; Panoutsakopoulou V; Trimble LA; Alt FW; Cantor H
J Exp Med; 2002 Jul; 196(1):87-95. PubMed ID: 12093873
[TBL] [Abstract][Full Text] [Related]
38. The IL-2 receptor promotes proliferation, bcl-2 and bcl-x induction, but not cell viability through the adapter molecule Shc.
Lord JD; McIntosh BC; Greenberg PD; Nelson BH
J Immunol; 1998 Nov; 161(9):4627-33. PubMed ID: 9794391
[TBL] [Abstract][Full Text] [Related]
39. bcl-xL and RAG genes are induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes.
Tsimbouri P; Drotar ME; Coy JL; Wilson JB
Oncogene; 2002 Aug; 21(33):5182-7. PubMed ID: 12140768
[TBL] [Abstract][Full Text] [Related]
40. Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells.
Solvason N; Wu WW; Kabra N; Lund-Johansen F; Roncarolo MG; Behrens TW; Grillot DA; Nunez G; Lees E; Howard M
J Exp Med; 1998 Apr; 187(7):1081-91. PubMed ID: 9529324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
